NASDAQ : OPRX
OptimizeRx Corporation — Key statistics
Healthcare · Health Information Services · United States
Last price 9.37 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 176.49M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 175.55M |
| Enterprise Value | 170.94M |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 11, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 18.84M |
| Shares Outstanding | 18.84M |
| Shares Change (YoY) | +3.84% |
| Shares Change (QoQ) | +0.13% |
| Owned by Insiders (%) | 15.14% |
| Owned by Institutions (%) | 61.52% |
| Float | 14.48M |
Ratios
| Measure | Value |
|---|
| PE Ratio | 37.87 |
| Forward PE | 10.12 |
| PS Ratio | 1.78 |
| Forward PS | 1.76 |
| PB Ratio | 1.34 |
| P/TBV Ratio | 8.16 |
| P/FCF Ratio | 9.56 |
| P/OCF Ratio | 9.52 |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | 37.15 |
| EV / Sales | 1.73 |
| EV / EBITDA | 10.99 |
| EV / EBIT | 15.18 |
| EV / FCF | 9.31 |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 5.58 |
| Quick Ratio | 5.27 |
| Debt / Equity | 0.15 |
| Debt / EBITDA | 1.23 |
| Debt / FCF | 1.06 |
| Interest Coverage | 2.41 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | 3.68% |
| Return on Assets (ROA) | 4.22% |
| Return on Invested Capital (ROIC) | 5.91% |
| Return on Capital Employed (ROCE) | 7.29% |
| Weighted Average Cost of Capital (WACC) | 11.70% |
| Revenue Per Employee | $741,759 |
| Profits Per Employee | $34,594 |
| Employee Count | 133 |
| Asset Turnover | 0.59 |
| Inventory Turnover | n/a |
Taxes
| Measure | Value |
|---|
| Income Tax | 2.15M |
| Effective Tax Rate | 31.85% |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 1.26 |
| 52-Week Price Change | -54.67% |
| 50-Day Moving Average | 8.20 |
| 200-Day Moving Average | 7.30 |
| Relative Strength Index (RSI) | 63.58 |
| Average Volume (20 Days) | 136,867 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 1.08M |
| Short Previous Month | 1.12M |
| Short % of Shares Out | 5.72% |
| Short % of Float | 7.45% |
| Short Ratio (days to cover) | 6.18 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 98.65M |
| Gross Profit | 72.24M |
| Operating Income | 11.26M |
| Pretax Income | 6.75M |
| Net Income | 4.60M |
| EBITDA | 15.55M |
| EBIT | 11.26M |
| Earnings Per Share (EPS) | $0.25 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 24.10M |
| Total Debt | 19.48M |
| Net Cash | 4.62M |
| Net Cash Per Share | $0.25 |
| Equity (Book Value) | 131.08M |
| Book Value Per Share | 6.96 |
| Working Capital | 44.44M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | 18.43M |
| Capital Expenditures | -77,000 |
| Depreciation & Amortization | 4.29M |
| Net Borrowing | -10.31M |
| Free Cash Flow | 18.36M |
| FCF Per Share | $0.97 |
Margins
| Measure | Value |
|---|
| Gross Margin | 73.22% |
| Operating Margin | 11.42% |
| Pretax Margin | 6.84% |
| Profit Margin | 4.66% |
| EBITDA Margin | 15.76% |
| EBIT Margin | 11.42% |
| FCF Margin | 18.61% |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -3.84% |
| Shareholder Yield | -3.84% |
| Earnings Yield | 2.64% |
| FCF Yield | 10.46% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $12.60 |
| Price Target Difference | 35.19% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 6 |
| Revenue Growth Forecast (3Y) | -0.52% |
| EPS Growth Forecast (3Y) | 0.63% |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | May 14, 2018 |
| Split Type | Reverse |
| Split Ratio | 1:3 |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 4.46 |
| Piotroski F-Score | 7 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |